{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T02:36:33Z","timestamp":1776825393310,"version":"3.51.2"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:00:00Z","timestamp":1773446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the General Project of the Medical and Health of Zhejiang Province","award":["2022KY1423"],"award-info":[{"award-number":["2022KY1423"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"DOI":"10.1186\/s12944-026-02927-0","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T08:24:09Z","timestamp":1773476649000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Germacrone suppresses renal cancer growth by regulating c-Fos-mediated lipid metabolism"],"prefix":"10.1186","volume":"25","author":[{"given":"Binqi","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruikai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiantian","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taian","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,14]]},"reference":[{"key":"2927_CR1","first-page":"7","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71(1):7\u201333.","journal-title":"CA Cancer J Clin"},{"key":"2927_CR2","doi-asserted-by":"crossref","unstructured":"Voelker R. What Is Renal Cell Carcinoma? Jama. 2025;333(7):644.","DOI":"10.1001\/jama.2024.22440"},{"key":"2927_CR3","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12943-017-0646-3","volume":"16","author":"X Luo","year":"2017","unstructured":"Luo X, Cheng C, Tan Z, Li N, Tang M, Yang L, et al. Emerging roles of lipid metabolism in cancer metastasis. Mol Cancer. 2017;16(1):76.","journal-title":"Mol Cancer"},{"key":"2927_CR4","doi-asserted-by":"publisher","first-page":"11539","DOI":"10.3390\/ijms150711539","volume":"15","author":"L Jiang","year":"2014","unstructured":"Jiang L, Wang H, Li J, Fang X, Pan H, Yuan X, et al. Up-regulated FASN expression promotes transcoelomic metastasis of ovarian cancer cell through epithelial-mesenchymal transition. Int J Mol Sci. 2014;15(7):11539\u201354.","journal-title":"Int J Mol Sci"},{"key":"2927_CR5","doi-asserted-by":"publisher","first-page":"40509","DOI":"10.1038\/srep40509","volume":"7","author":"QQ Tan","year":"2017","unstructured":"Tan QQ, Liu W, Zhu F, Lei CL, Wang XP. Fatty acid synthase 2 contributes to diapause preparation in a beetle by regulating lipid accumulation and stress tolerance genes expression. Sci Rep. 2017;7:40509.","journal-title":"Sci Rep"},{"key":"2927_CR6","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41419-021-03999-9","volume":"12","author":"TB Wang","year":"2021","unstructured":"Wang TB, Geng M, Jin H, Tang AG, Sun H, Zhou LZ, et al. SREBP1 site 1 protease inhibitor PF-429242 suppresses renal cell carcinoma cell growth. Cell Death Dis. 2021;12(8):717.","journal-title":"Cell Death Dis"},{"key":"2927_CR7","doi-asserted-by":"crossref","unstructured":"Sethi G, Shanmugam MK, Kumar AP. SREBP-1c as a molecular bridge between lipogenesis and cell cycle progression of clear cell renal carcinoma. Biosci Rep. 2017;37(6):BSR20171270.","DOI":"10.1042\/BSR20171270"},{"key":"2927_CR8","doi-asserted-by":"crossref","unstructured":"Lee JH, Jeon YG, Lee KH, Lee HW, Park J, Jang H, et al. RNF20 suppresses Tumorigenesis by inhibiting the SREBP1c-PTTG1 axis in kidney cancer. Mol Cell Biol. 2017;37(22):e00265-17.","DOI":"10.1128\/MCB.00265-17"},{"key":"2927_CR9","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41418-023-01248-4","volume":"31","author":"GL Rampioni Vinciguerra","year":"2024","unstructured":"Rampioni Vinciguerra GL, Capece M, Scafetta G, Rentsch S, Vecchione A, Lovat F, et al. Role of Fra-2 in cancer. Cell Death Differ. 2024;31(2):136\u201349.","journal-title":"Cell Death Differ"},{"key":"2927_CR10","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41419-024-06451-w","volume":"15","author":"Y Gui","year":"2024","unstructured":"Gui Y, Qian X, Ding Y, Chen Q, Fangyu Y, Ye Y, et al. c-Fos regulated by TMPO\/ERK axis promotes 5-FU resistance via inducing NANOG transcription in colon cancer. Cell Death Dis. 2024;15(1):61.","journal-title":"Cell Death Dis"},{"key":"2927_CR11","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1093\/jnci\/djad142","volume":"115","author":"K Lu","year":"2023","unstructured":"Lu K, Wang HC, Tu YC, Chang CC, Lou PJ, Chang TC, Lin JJ. Suppressing c-FOS expression by G-quadruplex ligands inhibits osimertinib-resistant non-small cell lung cancer. J Natl Cancer Inst. 2023;115(11):1383\u201391.","journal-title":"J Natl Cancer Inst"},{"key":"2927_CR12","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/bjc.2013.774","volume":"110","author":"L Oliveira-Ferrer","year":"2014","unstructured":"Oliveira-Ferrer L, R\u00f6\u00dfler K, Haustein V, Schr\u00f6der C, Wicklein D, Maltseva D, et al. c-FOS suppresses ovarian cancer progression by changing adhesion. Br J Cancer. 2014;110(3):753\u201363.","journal-title":"Br J Cancer"},{"key":"2927_CR13","doi-asserted-by":"crossref","unstructured":"Mario M, Josef G, Alexandra NMF, Markus FW, Christiane T, Rolf S-H, Hartmut B, et al. The proto-oncoprotein c-Fos negatively regulates hepatocellular tumorigenesis. Oncogene. 2003;22(43):6725\u201338.","DOI":"10.1038\/sj.onc.1206781"},{"key":"2927_CR14","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.bioorg.2019.03.015","volume":"87","author":"TK Lee","year":"2019","unstructured":"Lee TK, Lee D, Lee SR, Ko YJ, Sung Kang K, Chung SJ, et al. Sesquiterpenes from Curcuma zedoaria rhizomes and their cytotoxicity against human gastric cancer AGS cells. Bioorg Chem. 2019;87:117\u201322.","journal-title":"Bioorg Chem"},{"key":"2927_CR15","doi-asserted-by":"crossref","unstructured":"H M, T NMAK. K, M H: Anti-inflammatory sesquiterpenes from Curcuma zedoaria. Nat Prod Res. 2006;20(7):680\u20135.","DOI":"10.1080\/14786410500462900"},{"key":"2927_CR16","doi-asserted-by":"crossref","unstructured":"H M, K N TM. M Y: Hepatoprotective constituents from zedoariae rhizoma: absolute stereostructures of three new carabrane-type sesquiterpenes, curcumenolactones A, B, and C. Bioorg Med Chem. 2001;9(4):909\u201316.","DOI":"10.1016\/S0968-0896(00)00306-0"},{"key":"2927_CR17","doi-asserted-by":"crossref","unstructured":"Yi C, Zongping Z, Jiao C, Yongfeng Z, Boonjai L, Meigui L, et al. Terpenoids from Curcumae Rhizoma: their anticancer effects and clinical uses on combination and versus drug therapies. Biomed Pharmacother. 2021;138:111350.","DOI":"10.1016\/j.biopha.2021.111350"},{"key":"2927_CR18","doi-asserted-by":"crossref","unstructured":"Zhangfeng Z, Xiuping C, Wen T, Zengtao X, Keyuan Z, Tie W, et al. Germacrone inhibits the proliferation of breast cancer cell lines by inducing cell cycle arrest and promoting apoptosis. Eur J Pharmacol. 2011;667(1-3):50\u20135.","DOI":"10.1016\/j.ejphar.2011.03.041"},{"key":"2927_CR19","doi-asserted-by":"crossref","unstructured":"Mi-Sun L, Se-Young C, Kwang Won J. Germacrone Inhibits Estrogen receptor \u03b1-mediated transcription in MCF-7 breast cancer cells. Phytother Res. 2016;30(12):2036\u201343.","DOI":"10.1002\/ptr.5711"},{"key":"2927_CR20","doi-asserted-by":"crossref","unstructured":"Yunyi L, Wei W, Bin F, Fengyun M, Qian Z, Pengyi D, et al. Anti-tumor effect of germacrone on human hepatoma cell lines through inducing G2\/M cell cycle arrest and promoting apoptosis. Eur J Pharmacol. 2012;698(1-3):95\u2013102.","DOI":"10.1016\/j.ejphar.2012.10.013"},{"key":"2927_CR21","doi-asserted-by":"crossref","unstructured":"Yun-Yi L, Qian Z, Bin F, Wei W, Feng-Yun M, Sadia R, et al. Germacrone induces apoptosis in human hepatoma HepG2 cells through inhibition of the JAK2\/STAT3 signalling pathway. J Huazhong Univ Sci Technolog Med Sci. 2013;33(3):339\u201345.","DOI":"10.1007\/s11596-013-1121-z"},{"key":"2927_CR22","doi-asserted-by":"crossref","unstructured":"Bo L, Yue-Qiu G, Xiao-Min W, Yu-Chun W, Li-Qi F. Germacrone inhibits the proliferation of glioma cells by promoting apoptosis and inducing cell cycle arrest. Mol Med Rep. 2014;10(2):1046\u201350.","DOI":"10.3892\/mmr.2014.2290"},{"key":"2927_CR23","doi-asserted-by":"crossref","unstructured":"Ren Z, Ji H, Kaiwen G, Wanxin L, Fei Y, Qingming W, et al. Germacrone inhibits cell proliferation and induces apoptosis in human Esophageal Squamous cell Carcinoma cells. Biomed Res Int. 2020;2020:7643248.","DOI":"10.1155\/2020\/7643248"},{"key":"2927_CR24","doi-asserted-by":"crossref","unstructured":"Daniel MM, Rozbeh J, Marina I, Takahiro S, Andreas E, Chen L, et al. N: monitoring drug target engagement in cells and tissues using the cellular thermal shift assay. Science. 2013;341(6141):84\u20137.","DOI":"10.1126\/science.1233606"},{"key":"2927_CR25","doi-asserted-by":"crossref","unstructured":"Peter EC, Ana JG-S. Mechanisms of BCL-2 family proteins in mitochondrial apoptosis. Nat Rev Mol Cell Biol. 2023;24(10):732\u201348.","DOI":"10.1038\/s41580-023-00629-4"},{"key":"2927_CR26","doi-asserted-by":"crossref","unstructured":"Gayatri S, Dibyaranjan S, Pratima K, Meesala Krishna M. A review on caspases: key regulators of biological activities and apoptosis. Mol Neurobiol. 2023;60(10):5805\u201337.","DOI":"10.1007\/s12035-023-03433-5"},{"key":"2927_CR27","doi-asserted-by":"crossref","unstructured":"Yanxia Q, Kui C, Weihong G, Xinghua D, Ruihong L, Yanan C, et al. Small size fullerenol nanoparticles suppress lung metastasis of breast cancer cell by disrupting actin dynamics. J Nanobiotechnol. 2018;16(1):54.","DOI":"10.1186\/s12951-018-0380-z"},{"key":"2927_CR28","doi-asserted-by":"crossref","unstructured":"Elsa Correia F, Nan M, Ehsan G, Peter G, Mick B, Noel WC, et al. Measurement of elastic properties of prostate cancer cells using AFM. Analyst. 2008;133(11):1498\u2013500.","DOI":"10.1039\/b803355b"},{"key":"2927_CR29","doi-asserted-by":"crossref","unstructured":"Ming-Heng W, Tse-Ming H, Hui-Wen C, Szu-Hua P, Yu-Ray L, Hsiao-Chin H, et al. Galectin-1-mediated tumor invasion and metastasis, up-regulated matrix metalloproteinase expression, and reorganized actin cytoskeletons. Mol Cancer Res. 2009;7(3):311\u20138.","DOI":"10.1158\/1541-7786.MCR-08-0297"},{"key":"2927_CR30","doi-asserted-by":"crossref","unstructured":"Pernilla vN, Erika G, Jouko L, Rui L, Nami S, Olli C, et al. Actin-associated protein palladin promotes tumor cell invasion by linking extracellular matrix degradation to cell cytoskeleton. Mol Biol Cell. 2014;25(17):2556\u201370.","DOI":"10.1091\/mbc.e13-11-0667"},{"key":"2927_CR31","doi-asserted-by":"crossref","unstructured":"Angel Matias S, Marina Ines F, Eleonora R, Elena C, Simone P, Mario P, et al. LH and FSH promote migration and invasion properties of a breast cancer cell line through regulatory actions on the actin cytoskeleton. Mol Cell Endocrinol. 2016;437:22\u201334.","DOI":"10.1016\/j.mce.2016.08.009"},{"key":"2927_CR32","doi-asserted-by":"crossref","unstructured":"Dalit B, Hynda K, Justin LS, Holly A, Anil KK, Mark JH, et al. Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton. Cancer Res. 2008;68(15):6241\u201350.","DOI":"10.1158\/0008-5472.CAN-07-6849"},{"key":"2927_CR33","doi-asserted-by":"crossref","unstructured":"Wenwei X, Roman M, Byungkyu K, Lijuan W, John M, Todd S. Cell stiffness is a biomarker of the metastatic potential of ovarian cancer cells. PLoS ONE. 2012;7(10):e46609.","DOI":"10.1371\/journal.pone.0046609"},{"key":"2927_CR34","doi-asserted-by":"crossref","unstructured":"Alicia C-M, Mario E, Javier T, Montserrat C, Alvaro SP. Effect of actin organization on the stiffness of living breast cancer cells revealed by peak-force modulation atomic force Microscopy. ACS Nano. 2016;10(3):3365\u201374.","DOI":"10.1021\/acsnano.5b07162"},{"key":"2927_CR35","doi-asserted-by":"crossref","unstructured":"Rozbeh J, Helena A, Hanna A, Marina I, Thomas L, P\u00e4r N, et al. The cellular thermal shift assay for evaluating drug target interactions in cells. Nat Protoc. 2014;9(9):2100\u201322.","DOI":"10.1038\/nprot.2014.138"},{"key":"2927_CR36","doi-asserted-by":"crossref","unstructured":"Gemma N, Marc G-A, Paula M, Joan Biel R, Claudia LDT, Nadine J, et al. Homodimerization of CB(2) cannabinoid receptor triggered by a bivalent ligand enhances cellular signaling. Pharmacol Res. 2024;208:107363.","DOI":"10.1016\/j.phrs.2024.107363"},{"key":"2927_CR37","doi-asserted-by":"crossref","unstructured":"Xiao-Hong X, Hong Z, Yuan-Yuan H, Xi-Dong G. Germacrone reverses Adriamycin resistance through cell apoptosis in multidrug-resistant breast cancer cells. Exp Ther Med. 2014;8(5):1611\u20135.","DOI":"10.3892\/etm.2014.1932"},{"key":"2927_CR38","doi-asserted-by":"crossref","unstructured":"Maty T, Yeela S, Ifat A, Eyal G, Sara S, Karl S. Comparative analysis of the APOL1 variants in the genetic landscape of renal Carcinoma cells. Cancers (Basel). 2022;14(3):733.","DOI":"10.3390\/cancers14030733"},{"key":"2927_CR39","doi-asserted-by":"crossref","unstructured":"Chee Wai F, Azhar A. Fatty acid synthase: an emerging target in cancer. Molecules. 2020;25(17):3935.","DOI":"10.3390\/molecules25173935"},{"key":"2927_CR40","doi-asserted-by":"crossref","unstructured":"Zhuo L, Yibin K. Lipid metabolism fuels cancer\u2019s spread. Cell Metab. 2017;25(2):228\u201330.","DOI":"10.1016\/j.cmet.2017.01.016"},{"key":"2927_CR41","doi-asserted-by":"crossref","unstructured":"Mengting W, Shuaikang P, Benjie S, Haizhou D, Hongwei J, Ziqi W, et al. Lipid metabolic reprograming: the unsung hero in breast cancer progression and tumor microenvironment. Mol Cancer. 2025;24(1):61.","DOI":"10.1186\/s12943-025-02258-1"},{"key":"2927_CR42","doi-asserted-by":"crossref","unstructured":"Xiangjian L, Can C, Zheqiong T, Namei L, Min T, Lifang Y, et al. Emerging roles of lipid metabolism in cancer metastasis. Mol Cancer. 2017;16(1):76.","DOI":"10.1186\/s12943-017-0646-3"},{"key":"2927_CR43","doi-asserted-by":"crossref","unstructured":"Kevin CC, McKenzie AW, Marjan R. Lipids in the tumor microenvironment: From cancer progression to treatment. Prog Lipid Res. 2020;80:101055.","DOI":"10.1016\/j.plipres.2020.101055"},{"key":"2927_CR44","doi-asserted-by":"crossref","unstructured":"Lijie Z, Yongbo L, Yuenan L, Youmiao Z, Junwei T, Mengting L, et al. Fatty acid oxidation mediated by Malonyl-CoA Decarboxylase represses renal cell Carcinoma progression. Cancer Res. 2023;83(23):3920\u201339.","DOI":"10.1158\/0008-5472.CAN-23-0969"},{"key":"2927_CR45","doi-asserted-by":"crossref","unstructured":"Sei N, Peter M, Igor A, Konstantin G, Alexei T, Alexander K, et al. Vladimir M K: LDL cholesterol counteracts the antitumour effect of tyrosine kinase inhibitors against renal cell Carcinoma. Br J Cancer. 2017;116(9):1203\u20137.","DOI":"10.1038\/bjc.2017.77"},{"key":"2927_CR46","doi-asserted-by":"crossref","unstructured":"Yihai C. Adipocyte and lipid metabolism in cancer drug resistance. J Clin Invest. 2019;129(8):3006\u201317.","DOI":"10.1172\/JCI127201"},{"key":"2927_CR47","doi-asserted-by":"crossref","unstructured":"Lisa MB, Ylenia P, Jonas D, Leslie EL, Vincent dL, Ali T, et al. Lipids and cancer: emerging roles in pathogenesis, diagnosis and therapeutic intervention. Adv Drug Deliv Rev. 2020;159:245\u201393.","DOI":"10.1016\/j.addr.2020.07.013"},{"key":"2927_CR48","doi-asserted-by":"crossref","unstructured":"T C, B R Jr F: Fos and Jun: the AP-1 connection. Cell. 1988;55(3):395\u20137.","DOI":"10.1016\/0092-8674(88)90024-4"},{"key":"2927_CR49","doi-asserted-by":"crossref","unstructured":"Cen J, Youzhi Z, Junsi Z, Huaying C, Weiwei L, Ruiwang X, et al. NR4A1 suppresses breast cancer growth by repressing c-Fos-mediated lipid and redox dyshomeostasis. Exp Mol Med. 2025;57(4):804\u201319.","DOI":"10.1038\/s12276-025-01430-3"},{"key":"2927_CR50","doi-asserted-by":"crossref","unstructured":"Shuai Y, Wenxi Z, Juntong D, Lizhi T, Tong Y, Peng X, et al. C-FOS promotes the formation of neutrophil extracellular traps and the recruitment of neutrophils in lung metastasis of triple-negative breast cancer. J Exp Clin Cancer Res. 2025;44(1):108.","DOI":"10.1186\/s13046-025-03370-2"},{"key":"2927_CR51","doi-asserted-by":"crossref","unstructured":"Huayang Y, Qiming K, Hang Y, Yanyu Q, Qin L, Liang L, et al. Alkannin triggered apoptosis and ferroptosis in gastric cancer by suppressing lipid metabolism mediated by the c-Fos\/SREBF1 axis. Phytomedicine. 2025;140:156604.","DOI":"10.1016\/j.phymed.2025.156604"},{"key":"2927_CR52","doi-asserted-by":"crossref","unstructured":"Eeshrita J, Ashwin Kumar J, Alessandro LF, Arnab C, Afiya D, Showket Y, et al. Inhibiting de novo lipogenesis identifies a therapeutic vulnerability in therapy-resistant colorectal cancer. Redox Biol. 2024;79:103458.","DOI":"10.1016\/j.redox.2024.103458"},{"key":"2927_CR53","doi-asserted-by":"crossref","unstructured":"Xueli B, Rui L, Ying M, Dongming X, Daqian X, Zhimin L. Lipid metabolism and cancer. J Exp Med. 2021;218(1):e20201606.","DOI":"10.1084\/jem.20201606"},{"key":"2927_CR54","doi-asserted-by":"crossref","unstructured":"Sirima S, Paranee M, Lawan S, Ratchanaporn C, Apichart S, Sunhapas S. Germacrone reduces Cisplatin-induced toxicity of renal proximal tubular cells via inhibition of organic cation transporter. Biol Pharm Bull. 2020;43(11):1693\u20138.","DOI":"10.1248\/bpb.b20-00392"},{"key":"2927_CR55","doi-asserted-by":"crossref","unstructured":"Ru X, Jiamin F, Qinpo H, Guolin H, Xia O, Yang D, et al. The effect and mechanism of Germacrone in ameliorating alcoholic fatty liver by inhibiting Nrf2\/Rbp4. Chin Med. 2025;20(1):77.","DOI":"10.1186\/s13020-025-01132-y"},{"key":"2927_CR56","unstructured":"Nizar MT, Eric J, Laurence A, Emre A, Chaan SN, Surena FM, et al. Everolimus versus sunitinib prospective evaluation in metastatic non-clear cell renal cell Carcinoma (ESPN): a randomized multicenter phase 2 trial. Eur Urol. 2015;69(5):866\u201374."},{"key":"2927_CR57","doi-asserted-by":"crossref","unstructured":"Xuefeng H, Beibei C, Yuanzhi H, Teng G, Zhe L, Ying L, et al. Improved self-assembled micelles based on supercritical fluid technology as a novel oral delivery system for enhancing germacrone oral bioavailability. Int J Pharm. 2019;569:118586.","DOI":"10.1016\/j.ijpharm.2019.118586"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-026-02927-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-026-02927-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-026-02927-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T01:42:11Z","timestamp":1776822131000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12944-026-02927-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,14]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2927"],"URL":"https:\/\/doi.org\/10.1186\/s12944-026-02927-0","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,14]]},"assertion":[{"value":"9 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research received approval from the ethics committee of Hangzhou Institute of Medicine, Chinese Academy of Sciences (Approval no.: AP-2025-04-0502, registration date: 2nd March, 2025).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors are aware of and consent to the publication of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"116"}}